Literature DB >> 27571902

Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection.

Arnold Reynaldi1, Timothy E Schlub2, Erwan Piriou3, Sidney Ogolla4, Odada P Sumba4, Ann M Moormann5, Rosemary Rochford6, Miles P Davenport1.   

Abstract

The combination of Epstein-Barr virus (EBV) infection and high malaria exposure are risk factors for endemic Burkitt lymphoma, and evidence suggests that infants in regions of high malaria exposure have earlier EBV infection and increased EBV reactivation. In this study we analyzed the longitudinal antibody response to EBV in Kenyan infants with different levels of malaria exposure. We found that high malaria exposure was associated with a faster decline of maternally derived immunoglobulin G antibody to both the EBV viral capsid antigen and EBV nuclear antigen, followed by a more rapid rise in antibody response to EBV antigens in children from the high-malaria-transmission region. We also observed the long-term persistence of anti-viral capsid antigen immunoglobulin M responses in children from the high-malaria region. More rapid decay of maternal antibodies was a major predictor of EBV infection outcome, because decay predicted time to EBV DNA detection, independent of high or low malaria exposure.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Burkitt Lymphoma; Epstein-Barr virus; P. falciparum malaria; antibody; immunity

Mesh:

Substances:

Year:  2016        PMID: 27571902      PMCID: PMC5079376          DOI: 10.1093/infdis/jiw396

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

Review 1.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

2.  Plasmodium falciparum infection is associated with Epstein-Barr virus reactivation in pregnant women living in malaria holoendemic area of Western Kenya.

Authors:  Ibrahim I Daud; Sidney Ogolla; Asito S Amolo; Eunice Namuyenga; Kenneth Simbiri; Elizabeth A Bukusi; Zipporah W Ng'ang'a; Robert Ploutz-Snyder; Peter O Sumba; Arlene Dent; Rosemary Rochford
Journal:  Matern Child Health J       Date:  2015-03

3.  Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children.

Authors:  Ann M Moormann; Kiprotich Chelimo; Odada P Sumba; Mary L Lutzke; Robert Ploutz-Snyder; Duane Newton; James Kazura; Rosemary Rochford
Journal:  J Infect Dis       Date:  2005-03-09       Impact factor: 5.226

4.  Pattern and persistence of the epitope-specific IgM response against human cytomegalovirus in renal transplant patients.

Authors:  Thomas F Müller; Dorothee Gicklhorn; Therese Jungraithmayr; Markus Eickmann; Harald Lange; Klaus Radsak; Marko Reschke
Journal:  J Clin Virol       Date:  2002-02       Impact factor: 3.168

5.  Study of Epstein Barr virus (EBV) antibodies: IgG and IgM anti-VCA, IgG anti-EA and Ig anti-EBNA obtained with an original microtiter technique: --serological criterions of primary and recurrent EBV infections and follow-up of infectious mononucleosis--seroepidemiology of EBV in Belgium based on 5178 sera from patients.

Authors:  M E Lamy; A M Favart; C Cornu; M Mendez; M Segas; G Burtonboy
Journal:  Acta Clin Belg       Date:  1982       Impact factor: 1.264

6.  Epstein-Barr virus (EBV) infection in infancy.

Authors:  K H Chan; J S Tam; J S Peiris; W H Seto; M H Ng
Journal:  J Clin Virol       Date:  2001-04       Impact factor: 3.168

7.  Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children.

Authors:  Ann M Moormann; Kiprotich Chelimo; Peter O Sumba; Daniel J Tisch; Rosemary Rochford; James W Kazura
Journal:  J Infect Dis       Date:  2007-02-06       Impact factor: 5.226

8.  Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study.

Authors:  Amolo S Asito; Erwan Piriou; Peter Sumba Odada; Nancy Fiore; Jaap M Middeldorp; Carole Long; Sheetij Dutta; David E Lanar; Walter G Jura; Collins Ouma; Juliana A Otieno; Ann M Moormann; Rosemary Rochford
Journal:  Infect Agent Cancer       Date:  2010-07-28       Impact factor: 2.965

9.  Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya.

Authors:  Erwan Piriou; Rhonda Kimmel; Kiprotich Chelimo; Jaap M Middeldorp; Peter Sumba Odada; Robert Ploutz-Snyder; Ann M Moormann; Rosemary Rochford
Journal:  J Med Virol       Date:  2009-06       Impact factor: 2.327

10.  Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.

Authors:  Lucy M Carpenter; Robert Newton; Delphine Casabonne; John Ziegler; Sam Mbulaiteye; Edward Mbidde; Henry Wabinga; Harold Jaffe; Valerie Beral
Journal:  Int J Cancer       Date:  2008-03-15       Impact factor: 7.396

View more
  9 in total

1.  Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas.

Authors:  Catherine S Forconi; Cormac P Cosgrove; Pryia Saikumar-Lakshmi; Christina E Nixon; Joslyn Foley; John Michael Ong'echa; Juliana A Otieno; Galit Alter; Christian Münz; Ann M Moormann
Journal:  Blood Adv       Date:  2018-05-22

2.  Fc functional antibodies in humans with severe H7N9 and seasonal influenza.

Authors:  Hillary A Vanderven; Lu Liu; Fernanda Ana-Sosa-Batiz; Thi Ho Nguyen; Yanmin Wan; Bruce Wines; P Mark Hogarth; Danielle Tilmanis; Arnold Reynaldi; Matthew S Parsons; Aeron C Hurt; Miles P Davenport; Tom Kotsimbos; Allen C Cheng; Katherine Kedzierska; Xiaoyan Zhang; Jianqing Xu; Stephen J Kent
Journal:  JCI Insight       Date:  2017-07-06

3.  Assessment of the Combined Effect of Epstein-Barr Virus and Plasmodium falciparum Infections on Endemic Burkitt Lymphoma Using a Multiplex Serological Approach.

Authors:  Ruth Aguilar; Delphine Casabonne; Cristina O'Callaghan-Gordo; Marta Vidal; Joseph J Campo; Nora Mutalima; Evelina Angov; Sheetij Dutta; Deepak Gaur; Chetan E Chitnis; Virander Chauhan; Angelika Michel; Silvia de Sanjosé; Tim Waterboer; Manolis Kogevinas; Rob Newton; Carlota Dobaño
Journal:  Front Immunol       Date:  2017-10-26       Impact factor: 7.561

4.  Seroprevalence of Epstein-Barr virus among children and adults in Tehran, Iran.

Authors:  S Sharifipour; K Davoodi Rad
Journal:  New Microbes New Infect       Date:  2020-01-07

Review 5.  How Does Epstein-Barr Virus Interact With Other Microbiomes in EBV-Driven Cancers?

Authors:  Yuxi Wen; Huan Xu; Juan Han; Runming Jin; Hongbo Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-02-23       Impact factor: 5.293

6.  Malaria Is Associated With Kaposi Sarcoma-Associated Herpesvirus Seroconversion in a Cohort of Western Kenyan Children.

Authors:  Katherine R Sabourin; Ibrahim Daud; Sidney Ogolla; Nazzarena Labo; Wendell Miley; Molly Lamb; Robert Newton; Denise Whitby; Rosemary Rochford
Journal:  J Infect Dis       Date:  2021-07-15       Impact factor: 5.226

7.  Whole-genome association study of antibody response to Epstein-Barr virus in an African population: a pilot.

Authors:  N Sallah; T Carstensen; K Wakeham; R Bagni; N Labo; M O Pollard; D Gurdasani; K Ekoru; C Pomilla; E H Young; S Fatumo; G Asiki; A Kamali; M Sandhu; P Kellam; D Whitby; I Barroso; R Newton
Journal:  Glob Health Epidemiol Genom       Date:  2017-11-27

8.  HIV-exposed infants with EBV infection have a reduced persistence of the immune response to the HBV vaccine.

Authors:  Silvia Baroncelli; Clementina Maria Galluzzo; Giuseppe Liotta; Mauro Andreotti; Stefano Orlando; Fausto Ciccacci; Robert Mphwere; Richard Luhanga; Jean Baptiste Sagno; Roberta Amici; Maria Cristina Marazzi; Marina Giuliano
Journal:  AIDS Res Ther       Date:  2021-08-04       Impact factor: 2.250

9.  In vitro Studies and Clinical Observations Imply a Synergistic Effect Between Epstein-Barr Virus and Dengue Virus Infection.

Authors:  Xiao-Mei Deng; Ling-Zhai Zhao; Xue-Ying Liang; Dan Li; Lei Yu; Fu-Chun Zhang; Hua Zhang; Zhong-Yu Liu; Pei Xu
Journal:  Front Microbiol       Date:  2021-06-18       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.